18 patents
Utility
Tofacitinib-containing Anhydrous Elastomer-based Gel Formulations
12 Oct 23
The present disclosure relates to novel topical formulations containing a tofacitinib and or a fingolimod that are useful for treating dermatological conditions, such as atopic dermatitis, psoriasis, vitiligo and eczema.
Iain Stuart, Russell Elliott, Yohan Hazot, Gareth Winckle, Ariel Margulis
Filed: 13 Jan 23
Utility
Stable Topical Tetracycline Compositions
20 Apr 23
Provided herein are compositions and methods for treating skin disorders, e.g., acne and/or rosacea.
Yohan HAZOT, Tal BERMAN, Jana ZAILER, Orit AMSALEM, David SCHUZ, Anat LONDON-DRORI
Filed: 19 Jun 18
Utility
Topical Composition Comprising Tofacitinib and Fingolimod
9 Feb 23
The present disclosure relates to novel topical formulations containing a tofacitinib and or a fingolimod that are useful for treating dermatological conditions, such as atopic dermatitis, psoriasis, and eczema.
Russell ELLIOTT, Yohan HAZOT, Gareth WINCKLE, Ariel MARGULIS
Filed: 31 Dec 20
Utility
Oil foamable carriers and formulations
6 Sep 22
A waterless foamable pharmaceutical composition suitable for external administration is disclosed.
Dov Tamarkin, Helena Shifrin, Rita Keynan, Enbal Ziv, Tal Berman, David Schuz, Elana Gazal
Filed: 17 Aug 18
Utility
Compositions and methods for treating rosacea and acne
10 May 22
Provided are compositions and methods for treating rosacea and acne.
Dov Tamarkin, Meir Eini, Yohan Hazot, Mitchell Shirvan, Tal Hetzroni Kedem, Rita Keynan
Filed: 20 Oct 20
Utility
Foamable compositions, breakable foams and their uses
11 Jan 22
A substantially surface active agent-free foamable composition which includes short-chain alcohol, water, polymer, fatty alcohol or fatty acid or a combination of fatty alcohol and fatty acid and propellant.
Dov Tamarkin, Enbal Ziv, Yohan Hazot, David Schuz
Filed: 22 Aug 18
Utility
Wax foamable vehicle and pharmaceutical compositions thereof
31 Aug 21
Unique foamable vehicles or carriers comprising at least one wax, waxy substance, counterpart or derivative, a stabilizer, water, and a propellant are provided.
Dov Tamarkin, Rita Keynan, David Schuz, Tal Berman
Filed: 18 Jun 19
Utility
Compositions and Methods for Treating Rosacea and Acne
8 Jul 21
Provided are compositions and methods for treating rosacea and acne.
Dov Tamarkin, Meir Eini, Yohan Hazot, Mitchell Shirvan, Tal Hetzroni Kedem, Rita Keynan
Filed: 20 Oct 20
Utility
Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
15 Jun 21
The present invention teaches a foamable pharmaceutical carrier comprising a benefit agent, selected from the group consisting of a dicarboxylic acid and a dicarboxylic acid ester; a stabilizer selected from the group consisting of at least one surface-active agent; at least one polymeric agent and mixtures thereof; a solvent selected from the group consisting of water, a hydrophilic solvent, a hydrophobic solvent, a potent solvent, a polar solvent, a silicone, an emollient, and mixtures thereof, wherein the benefit agent, stabilizer and solvent are selected to provide a composition that is substantially resistant to aging and to phase separation and or can substantially stabilize other active ingredients.
Dov Tamarkin, Doron Friedman, Tal Berman, Enbal Ziv, David Schuz
Filed: 16 Oct 20
Utility
Use of NEUROKININ-1 Antagonists to Treat Pruritus
10 Jun 21
The disclosure relates to the use of neurokinin-1 (NK-1) antagonists in treating pruritus in a subject, wherein i) the duration of the pruritus is about one year or longer, ii) the subject is about 40 years of age or older: iii) the subject has no inflammatory skin disease; and/or iv) the pruritus is idiopathic.
Steven BASTA, Paul KWON
Filed: 26 Jul 19
Utility
Use of NK-1 receptor antagonist serlopitant in pruritus
8 Jun 21
The invention relates to methods for treating pruritus with NK-1 receptor antagonists such as serlopitant.
Xiaoming Zhang, Edward F. Schnipper, Andrew J. Perlman, James W. Larrick
Filed: 2 Mar 20
Utility
Surfactant-free, water-free formable composition and breakable foams and their uses
6 Apr 21
A substantially surface active agent-free and foam adjuvant-free composition which includes a hydrophobic solvent, a wax and a propellant.
Dov Tamarkin, Elana Gazal, Irakliy Papiashvili, Yohan Hazot, David Schuz, Rita Keynan
Filed: 27 Jun 18
Utility
Compositions for the Improved Treatment of Acne and Related Disorders
18 Mar 21
Methods of treatment and dosage regimes using hydrophobic gel or foam composition comprising a tetracycline antibiotic in treating or alleviating a disorder including, acne, acne related symptoms, a tetracycline antibiotic responsive acne related disorder, skin disorder caused by a bacteria, and a tetracycline antibiotic responsive sebaceous gland disease, P. acne bacteria associated disorders and other superficial infections, including skin infections wherein the foam composition or gel is administered topically to a target area on a subject having the disorder and wherein the target area comprises an area of skin.
Dov Tamarkin, Elana Gazal, Rita Keynan, Meir Eini, David Schuz
Filed: 18 Sep 20
Utility
Surfactant-free water-free foamable compositions, breakable foams and gels and their uses
16 Mar 21
A substantially surface active agent free composition which includes a hydrophobic solvent, and/or a petrolatum, a paraffin wax and/or a fatty alcohol, a fatty acid and/or a wax and/or shea butter, with and without a propellant.
Dov Tamarkin, Elana Gazal, Irakliy Papiashvili, Yohan Hazot, David Schuz, Rita Keynan
Filed: 28 Dec 18
Utility
Use of NK-1 receptor antagonists in pruritus
6 Jul 20
The invention relates to methods for treating pruritus with NK-1 receptor antagonists such as serlopitant.
Xiaoming Zhang, Edward F. Schnipper, Andrew J. Perlman, James W. Larrick
Filed: 24 Mar 19
Utility
Use of NK-1 receptor antagonist serlopitant in pruritus
13 Apr 20
The invention relates to methods for treating pruritus with NK-1 receptor antagonists such as serlopitant.
Xiaoming Zhang, Edward F. Schnipper, Andrew J. Perlman, James W. Larrick
Filed: 24 Mar 19
Utility
Use of NK-1 Receptor Antagonist Serlopitant In Pruritus
19 Feb 20
The invention relates to methods for treating pruritus with NK-1 receptor antagonists such as serlopitant.
Xiaoming ZHANG, Edward F. SCHNIPPER, Andrew J. PERLMAN, James W. LARRICK
Filed: 24 Mar 19
Utility
Use of NK-1 Receptor Antagonists In Pruritus
19 Feb 20
The invention relates to methods for treating pruritus with NK-1 receptor antagonists such as serlopitant.
Xiaoming ZHANG, Edward F. SCHNIPPER, Andrew J. PERLMAN, James W. LARRICK
Filed: 24 Mar 19
- Prev
- 1
- Next
Patents are sorted by USPTO publication date, most recent first